Johnson & Johnson
JNJ
NYSE
12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 01/01/2023 | |
---|---|---|---|---|---|
Revenue | 6.46% | -1.36% | -6.63% | -14.30% | -14.70% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.46% | -1.36% | -6.63% | -14.30% | -14.70% |
Cost of Revenue | 6.70% | -3.46% | -7.93% | -17.17% | -17.62% |
Gross Profit | 6.36% | -0.40% | -6.04% | -12.95% | -13.34% |
SG&A Expenses | 5.70% | -6.16% | -12.93% | -21.30% | -20.69% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 6.38% | -4.85% | -8.92% | -16.02% | -15.76% |
Operating Income | 6.69% | 8.55% | -0.27% | -9.51% | -11.81% |
Income Before Tax | -22.20% | -30.85% | -26.28% | -39.84% | -15.00% |
Income Tax Expenses | -41.92% | -33.16% | -10.41% | 16.53% | 57.48% |
Earnings from Continuing Operations | -18.59% | -30.53% | -27.93% | -43.76% | -21.59% |
Earnings from Discontinued Operations | 4,806.12% | 14,772.97% | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 95.94% | 80.74% | -28.92% | -35.83% | -14.07% |
EBIT | 6.69% | 8.55% | -0.27% | -9.51% | -11.81% |
EBITDA | 7.92% | 5.57% | -1.98% | -9.93% | -12.39% |
EPS Basic | 100.92% | 86.90% | -28.44% | -35.65% | -13.84% |
Normalized Basic EPS | 7.35% | 19.71% | 9.74% | -2.76% | -5.79% |
EPS Diluted | 102.06% | 87.47% | -28.35% | -35.72% | -13.84% |
Normalized Diluted EPS | 7.98% | 20.08% | 10.12% | -2.30% | -5.72% |
Average Basic Shares Outstanding | -0.14% | -1.55% | -0.59% | -0.36% | -0.16% |
Average Diluted Shares Outstanding | -1.03% | -2.07% | -1.15% | -0.79% | -0.27% |
Dividend Per Share | 5.62% | 5.94% | 6.26% | 6.60% | 6.21% |
Payout Ratio | -0.61% | -0.57% | 0.48% | 0.65% | 0.23% |